United States Genetic Testing Market valuation $54.21 billion by 2033 - Exclusive Report by DatamIntelligence

"The global genetic testing market size reached US$14.72 billion in 2024 and is expected to reach US$54.21 billion by 2033, growing at a CAGR of 15.4 % during the forecast period of 2025-2033" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/genetic-testing-market?sp

United States: Recent Industry Developments

✅ In September 2025, 23andMe launched a new direct-to-consumer genetic test offering expanded insights into hereditary diseases, pharmacogenomics, and personalized wellness. The test integrates AI-driven analysis for enhanced accuracy. It empowers consumers and healthcare providers with actionable genetic insights.

✅ In August 2025, Invitae Corporation completed the acquisition of a U.S.-based startup specializing in high-throughput genetic sequencing for rare disease diagnostics. The acquisition strengthens Invitae's portfolio and accelerates access to advanced testing services. It supports faster identification and management of hereditary conditions.

✅ In July 2025, Thermo Fisher Scientific invested $75 million to expand its genetic testing R&D and clinical lab capabilities in Massachusetts. The investment focuses on next-generation sequencing, bioinformatics, and automation. It enhances the scalability and speed of genetic analysis in clinical settings.

✅ In June 2025, Color Genomics launched a cloud-based genetic testing platform integrating AI for risk assessment of hereditary cancers and cardiovascular diseases. The platform offers clinicians real-time decision support. It improves early detection and personalized treatment strategies.

Japan: Recent Industry Developments

✅ In September 2025, Fujirebio launched a new genetic testing panel for oncology and inherited disorders in Japanese hospitals and clinics. The panel combines high-throughput sequencing with AI-driven interpretation. It provides accurate, actionable results for patient care and research.

✅ In August 2025, SRL, Inc. invested in expanding its genetic testing laboratories and automation capabilities to accelerate clinical diagnostics. The investment focuses on rare disease, oncology, and pharmacogenomic testing. It strengthens Japan's domestic capacity for advanced genomic services.

✅ In July 2025, Takara Bio completed the acquisition of a Japanese startup specializing in rapid genetic testing kits for personalized medicine. The acquisition broadens Takara Bio's genetic testing portfolio. It supports faster clinical decision-making and improved patient outcomes.

✅ In June 2025, Sysmex Corporation launched a next-generation sequencing platform for clinical genetics, integrating AI-based variant interpretation. The platform enables faster, accurate, and high-throughput analysis. It targets hospitals, research centers, and diagnostic laboratories across Japan.

Genetic Testing Market: Drivers

The genetic testing market is experiencing significant growth due to rising demand for early disease detection, personalized medicine, and preventive healthcare solutions. Genetic tests enable identification of inherited disorders, predisposition to complex diseases, pharmacogenomic profiling, and carrier screening, supporting tailored treatment plans and improved patient outcomes. Increasing awareness among healthcare providers and patients, along with the growing prevalence of chronic and genetic disorders, is driving adoption of these tests. Technological advancements in next-generation sequencing (NGS), PCR-based methods, microarrays, and bioinformatics tools are enhancing test accuracy, speed, and scalability. Additionally, expanding healthcare infrastructure, government initiatives, and investments in genomics research are further supporting market growth.

Innovations in non-invasive prenatal testing (NIPT), liquid biopsy, and multi-gene panels are enabling broader applications and earlier detection of diseases. Integration with electronic health records (EHRs), AI-based analytics, and telemedicine platforms is improving data interpretation, patient management, and clinical decision-making. Growing focus on personalized therapies, oncology diagnostics, and precision medicine is boosting demand for comprehensive genetic testing solutions. Collaborations between biotechnology firms, research institutions, and healthcare providers are accelerating development and commercialization of advanced testing technologies. Collectively, these factors are driving sustained growth in the genetic testing market as healthcare systems increasingly prioritize precision, early intervention, and patient-centered care.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/genetic-testing-market?sp

Genetic Testing Market: Major Players

Abbott Laboratories, Bio-Rad Laboratories Inc., Illumina Inc., Myriad Genetics Inc., Danaher Corporation, Quest Diagnostics Incorporated, MedGenome, LabCorp, 3billion, Inc., and Blueprint Genetics, among others.

Segment Covered in the Genetic Testing Market:

➥ By Type: Carrier Testing, Diagnostic Testing, Forensic Testing, New-born Screening, Others

➥ By Sample: Blood, Hair, Saliva, Others

➥ By Technology: Biochemical Genetic Testing, Chromosomal Genetic Testing, Others

➥ By Disease: Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Rare Diseases, Others

Research Process:

Both primary and secondary data sources have been used in the Genetic Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Genetic Testing Market Research Industry:

➠ Who leads the Genetic Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Genetic Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Genetic Testing market growth?
➠ What are the dominant sales and distribution strategies in the Genetic Testing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=genetic-testing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.